Xenon Anesthesia
Xenon Anesthesia - Related Videos
16:20
Hyperpolarized Xenon for NMR and MRI Applications
0 Views •
Cited by 28 •
2012
The production of hyperpolarized xenon by means of spin exchange optical pumping (SEOP) is described. This method yields a ~10000-fold enhancement of the nuclear spin polarization of Xe-129 and has applications in nuclear magnetic resonance spectroscopy and imaging. Examples of gas phase and solution state experiments are given.
09:55
Troubleshooting and Quality Assurance in Hyperpolarized Xenon Magnetic Resonance Imaging: Tools for High-Quality Image Acquisition
0 Views •
2024
Here, we present a protocol for obtaining high-quality hyperpolarized xenon-129 magnetic resonance images, covering hardware, software, data acquisition, sequence selection, data management, k-space utilization, and noise analysis.
14:01
Anesthesia Induction and Maintenance
0 Views •
2016
Source: Kay Stewart, RVT, RLATG, CMAR; Valerie A. Schroeder, RVT, RLATG. University of Notre Dame, IN The Guide for the Care and Use of Laboratory Animals ("The Guide") states that pain assessment and alleviation are integral components of the veterinary care of laboratory animals. The definition of anesthesia is the loss of feeling or sensation. It is a dynamic event involving changes in anesthetic depth with respect to an animal's metabolism, surgical stimulation, or variations in the...
01:36
Anesthesia and Monitoring in a Rabbit Model
0 Views •
2026
All animal procedures described here must be conducted in accordance with institutional animal ethics guidelines and approved by IACUC. All procedures must follow the principles of the 3Rs—Replacement, Reduction, and Refinement—and must be performed by trained personnel. Anesthesia is an essential component of rabbit surgical and experimental procedures because it prevents pain, reduces stress responses, and helps immobilize the animal during handling and manipulation when general anesthesia is...
01:31
Anesthesia and Monitoring in a Pig Model
0 Views •
2026
All animal procedures described here must be conducted in accordance with institutional animal ethics guidelines and approved by IACUC. All procedures must follow the principles of the 3Rs—Replacement, Reduction, and Refinement—and must be performed by trained personnel. Pigs are commonly used in biomedical and surgical research because of their anatomical and physiological similarities to humans. During procedures, anesthesia prevents pain, reduces stress, limits movement, and supports animal...
FAQs
Low blood-gas solubility supports relatively rapid uptake and elimination, making the timing of anesthetic onset and recovery especially relevant when evaluating xenon. Statistical analyses can therefore examine recovery time alongside anesthetic depth, helping determine whether observed differences between xenon and other agents reflect meaningful changes in how quickly patients reach or leave the anesthetic state.
Inhibition of N-methyl-D-aspartate receptors provides a mechanistic basis for xenon-associated unconsciousness and helps connect biological action with measured anesthetic depth. In research, this mechanism is considered alongside clinical outcomes rather than treated as a complete measure of efficacy, because statistical comparisons also evaluate recovery, cardiovascular responses, and adverse events.
Key variables include anesthetic depth, recovery time, cardiovascular responses, and adverse events. Together, these measures address both whether anesthesia is effective and whether it produces unwanted effects. Examining several outcomes prevents conclusions from relying on a single result and allows comparisons to reflect the broader balance between anesthetic performance and safety.
Statistical analysis quantifies treatment differences and the uncertainty surrounding them, allowing investigators to judge more than whether outcomes differ numerically. For xenon, the relevant question is whether changes in anesthetic depth, recovery time, cardiovascular responses, or adverse events are sufficiently important to represent a clinically meaningful benefit in a particular patient population.
A comparison begins by evaluating xenon against other anesthetic agents using predefined outcomes such as anesthetic depth, recovery time, cardiovascular responses, and adverse events. The resulting measurements are analyzed to estimate treatment differences and their uncertainty. This workflow connects physiological and clinical observations with an evidence-based assessment of xenon’s efficacy and safety.
A result observed in one patient population may not establish the same benefit in another, so xenon studies must interpret treatment differences in relation to the population examined. Statistical evaluation helps determine whether patterns in recovery, anesthetic depth, cardiovascular responses, or adverse events support meaningful advantages for specific groups rather than for all patients generally.